|[October 04, 2013]
Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of BioScrip, Inc.
BENSALEM, Pa. --(Business Wire)--
Law Offices of Howard G. Smith announces that it is investigating
potential claims on behalf of shareholders of BioScrip, Inc. ("BioScrip"
or the "Company") (NASDAQ:BIOS). The investigation focuses on certain
statements issued by the Company concerning BioScrip's business and
BioScrip provides home infusion, other home care services, and pharmacy
benefit management services in the United States. The investigation is
related to the Company's September 23, 2013, disclosure that the United
States Attorney's Office for the Southern District of New York and the
New York State Attorney General's Medicaid Fraud Control Unit have
undertaken an investigation regarding the distribution of the Novartis
Pharmaceuticals Corporation product Exjade(R) by the
Company's legacy specialty pharmacy division. The Company further
disclosed that it has provided documents and information to the
government regarding the distribution of Exjade, pursuant to a civil
investigative demand and a subpoena. Following this news, the price of
BioScrip shares declined more than 18%, to a closing price of $8.47 per
share on September 24, 2013.
If you purchased BioScrip shares and still hold those shares, if you
have information or would like to learn more about these claims, or if
you wish to discuss these matters or have any questions concerning this
announcement or your rights or interests with respect to these matters,
please contact Howard G. Smith, Esquire, of Law Offices of Howard G.
Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by
telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to firstname.lastname@example.org,
or visit our website at http://www.howardsmithlaw.com.
[ Back To Technology News's Homepage ]